Form 4: ALX Oncology Holdings SVP Sells Shares to Cover Tax Obligations

Shelly Pinto, SVP of Finance and CAO at ALX Oncology Holdings Inc., sold 2,011 shares of common stock on July 7, 2025, at a weighted average price of $0.4501 to satisfy tax obligations related to restricted stock unit vesting.

Summary

• Shelly Pinto, the Senior Vice President of Finance and Chief Accounting Officer (SVP, FINANCE AND CAO) of ALX Oncology Holdings Inc. (ALXO), reported a transaction.
• The transaction involved the sale of 2,011 shares of ALX Oncology Holdings Inc. common stock.
• The sale occurred on July 7, 2025.
• The shares were sold at a weighted average price of $0.4501 per share, with individual transactions ranging from $0.45 to $0.46.
• The purpose of the sale was to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.
• Following this transaction, Shelly Pinto directly beneficially owns 86,809 shares of common stock.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary sale of shares by an executive to cover tax obligations related to RSU vesting, which is a common occurrence and generally neutral in sentiment regarding the company's operational or financial performance.

Positives

• The transaction indicates the vesting of restricted stock units (RSUs) for a senior executive, which is a common component of executive compensation and retention strategies.

Negatives

• A reduction of 2,011 shares in direct beneficial ownership by a senior executive occurred.

Future Outlook

NA

Management Comments

• The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

Industry Context

NA

Stakeholder Impact

• Shareholders: The sale represents a minor reduction in insider ownership, which is a routine event for tax purposes and not indicative of a change in management's view of the company's prospects.
• Employees: The vesting of RSUs demonstrates the company's compensation structure and retention mechanisms for its executives.

Key Dates

Keywords

ALX Oncology Holdings, ALXO, Shelly Pinto, Form 4, insider trading, stock sale, restricted stock units, RSU, tax obligations, corporate officer